| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.964 | 0 | 0.964 | HCV NS5B polymerase inhibitor | 0.916 0.001 DBMET01381 0.859 0.001 DBMET01382 0.913 0.001 DBMET01383 | ||
| 0.963 | 0.001 | 0.963 | RNA-directed RNA polymerase inhibitor | 0.92 0.001 DBMET01381 0.842 0.001 DBMET01382 0.886 0.001 DBMET01383 | ||
| 0.823 | 0.008 | 0.823 | Caspase 9 stimulant | 0.615 0.034 DBMET01381 0.662 0.028 DBMET01382 0.275 0.223 DBMET01383 | ||
| 0.742 | 0.002 | 0.757 | RNA-directed DNA polymerase inhibitor | 0.757 0.002 DBMET01381 0.693 0.003 DBMET01382 0.744 0.002 DBMET01383 | DBMET01381 | |
| 0.594 | 0.002 | 0.724 | Antimetabolite | 0.724 0.001 DBMET01381 0.404 0.003 DBMET01382 0.514 0.002 DBMET01383 | DBMET01381 | |
| 0.537 | 0.024 | 0.59 | Immunostimulant | 0.59 0.018 DBMET01381 0.429 0.042 DBMET01382 0.392 0.052 DBMET01383 | DBMET01381 | |
| 0.494 | 0.014 | 0.871 | DNA synthesis inhibitor | 0.573 0.009 DBMET01381 0.826 0.003 DBMET01382 0.871 0.002 DBMET01383 | DBMET01383 | |
| 0.424 | 0.005 | 0.636 | DNA directed RNA polymerase inhibitor | 0.483 0.004 DBMET01381 0.515 0.004 DBMET01382 0.636 0.004 DBMET01383 | DBMET01383 | |
| 0.391 | 0.003 | 0.436 | Ribonucleotide reductase inhibitor | 0.436 0.002 DBMET01381 0.2 0.007 DBMET01382 0.264 0.005 DBMET01383 | DBMET01381 | |
| 0.328 | 0.011 | 0.551 | Adenylate cyclase inhibitor | 0.442 0.006 DBMET01381 0.486 0.006 DBMET01382 0.551 0.005 DBMET01383 | DBMET01383 | |
| 0.28 | 0.004 | 0.325 | Ribonucleoside-diphosphate reductase inhibitor | 0.325 0.004 DBMET01381 0.127 0.015 DBMET01382 0.146 0.012 DBMET01383 | DBMET01381 | |
| 0.279 | 0.011 | 0.677 | UDP-glucose 4-epimerase inhibitor | 0.396 0.006 DBMET01381 0.677 0 DBMET01382 0.632 0.001 DBMET01383 | DBMET01382 | |
| 0.266 | 0.008 | 0.698 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.381 0.004 DBMET01381 0.698 0.001 DBMET01382 0.544 0.002 DBMET01383 | DBMET01382 | |
| 0.283 | 0.034 | 0.296 | Hepatoprotectant | 0.29 0.033 DBMET01381 0.296 0.031 DBMET01382 0.281 0.035 DBMET01383 | DBMET01382 | |
| 0.312 | 0.075 | 0.312 | Immunomodulator | 0.312 0.075 DBMET01381 0.216 0.145 DBMET01382 0.208 0.154 DBMET01383 | ||
| 0.271 | 0.038 | 0.317 | Peptidyltransferase inhibitor | 0.272 0.037 DBMET01381 0.303 0.024 DBMET01382 0.317 0.019 DBMET01383 | DBMET01383 | |
| 0.219 | 0.021 | 0.219 | Alkylator | 0.202 0.026 DBMET01381 0.2 0.026 DBMET01382 | ||
| 0.217 | 0.023 | 0.693 | DNA polymerase I inhibitor | 0.26 0.015 DBMET01381 0.521 0.004 DBMET01382 0.693 0.002 DBMET01383 | DBMET01383 | |
| 0.181 | 0.011 | 0.181 | Transcription factor NF kappa B stimulant | 0.146 0.017 DBMET01381 0.124 0.024 DBMET01382 0.18 0.011 DBMET01383 | ||
| 0.143 | 0.003 | 0.143 | Antiviral (Hepatitis D) | 0.123 0.004 DBMET01381 0.076 0.01 DBMET01382 0.135 0.003 DBMET01383 | ||
| 0.292 | 0.166 | 0.779 | DNA directed DNA polymerase inhibitor | 0.313 0.156 DBMET01381 0.338 0.143 DBMET01382 0.779 0.023 DBMET01383 | DBMET01383 | |
| 0.089 | 0.005 | 0.226 | Thymidylate synthase inhibitor | 0.166 0.003 DBMET01381 0.226 0.002 DBMET01382 0.099 0.004 DBMET01383 | DBMET01382 | |
| 0.093 | 0.016 | 0.663 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.172 0.008 DBMET01381 0.612 0.001 DBMET01382 0.663 0 DBMET01383 | DBMET01383 | |
| 0.105 | 0.028 | 0.42 | HIV-1 reverse transcriptase inhibitor | 0.131 0.018 DBMET01381 0.215 0.009 DBMET01382 0.42 0.004 DBMET01383 | DBMET01383 | |
| 0.115 | 0.049 | 0.115 | Toll-Like receptor 4 antagonist | 0.109 0.056 DBMET01381 0.094 0.08 DBMET01382 | ||
| 0.085 | 0.023 | 0.674 | Argininosuccinate synthase inhibitor | 0.162 0.01 DBMET01381 0.674 0.001 DBMET01382 0.639 0.001 DBMET01383 | DBMET01382 | |
| 0.071 | 0.014 | 0.101 | Adenine nucleotide translocase inhibitor | 0.074 0.012 DBMET01381 0.101 0.004 DBMET01382 0.072 0.013 DBMET01383 | DBMET01382 | |
| 0.054 | 0.009 | 0.204 | Purinergic P2Y2 antagonist | 0.065 0.007 DBMET01381 0.169 0.002 DBMET01382 0.204 0.002 DBMET01383 | DBMET01383 | |
| 0.061 | 0.02 | 0.078 | HCV NS3/NS4A protease inhibitor | 0.078 0.012 DBMET01381 | DBMET01381 | |
| 0.092 | 0.055 | 0.482 | Aminoacyl-tRNA synthetase inhibitor | 0.126 0.027 DBMET01381 0.316 0.006 DBMET01382 0.482 0.003 DBMET01383 | DBMET01383 | |
| 0.045 | 0.01 | 0.359 | Uridine phosphorylase inhibitor | 0.054 0.007 DBMET01381 0.359 0.001 DBMET01382 0.101 0.002 DBMET01383 | DBMET01382 | |
| 0.075 | 0.044 | 0.652 | Phosphofructokinase-1 inhibitor | 0.144 0.019 DBMET01381 0.608 0.002 DBMET01382 0.652 0.001 DBMET01383 | DBMET01383 | |
| 0.027 | 0.005 | 0.346 | Purinergic P2 agonist | 0.041 0.004 DBMET01381 0.099 0.001 DBMET01382 0.346 0.001 DBMET01383 | DBMET01383 | |
| 0.027 | 0.005 | 0.346 | Purinergic receptor agonist | 0.041 0.004 DBMET01381 0.099 0.001 DBMET01382 0.346 0.001 DBMET01383 | DBMET01383 | |
| 0.021 | 0.005 | 0.328 | Purinergic P2Y agonist | 0.035 0.004 DBMET01381 0.091 0.001 DBMET01382 0.328 0.001 DBMET01383 | DBMET01383 | |
| 0.193 | 0.179 | 0.193 | Caspase 3 stimulant | |||
| 0.24 | 0.226 | 0.24 | Apoptosis agonist | |||
| 0.028 | 0.018 | 0.231 | Purinergic P2X agonist | 0.038 0.013 DBMET01381 0.099 0.003 DBMET01382 0.231 0.001 DBMET01383 | DBMET01383 | |
| 0.05 | 0.04 | 0.072 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET01381 0.072 0.023 DBMET01382 0.066 0.026 DBMET01383 | DBMET01382 | |
| 0.038 | 0.033 | 0.662 | Thymidine kinase inhibitor | 0.058 0.014 DBMET01381 0.561 0.001 DBMET01382 0.662 0.001 DBMET01383 | DBMET01383 | |
| 0.011 | 0.006 | 0.068 | Purinergic P2Y2 agonist | 0.015 0.003 DBMET01381 0.068 0 DBMET01382 0.063 0 DBMET01383 | DBMET01382 | |
| 0.045 | 0.044 | 0.522 | Ornithine carbamoyltransferase inhibitor | 0.088 0.019 DBMET01381 0.496 0.002 DBMET01382 0.522 0.002 DBMET01383 | DBMET01383 | |
| 0.004 | 0.004 | 0.139 | Purinergic P2Y4 agonist | 0.005 0.003 DBMET01381 0.018 0.001 DBMET01382 0.139 0 DBMET01383 | DBMET01383 | |
| 0.03 | 0.03 | 0.768 | Fumarate hydratase inhibitor | 0.057 0.011 DBMET01381 0.747 0.001 DBMET01382 0.768 0.001 DBMET01383 | DBMET01383 | |
| 0.001 | 0.004 | 0.037 | Purinergic P2Y6 agonist | 0.003 0.002 DBMET01381 0.037 0 DBMET01382 0.031 0 DBMET01383 | DBMET01382 | |
| 0.014 | 0.021 | 0.241 | Purinergic P2T antagonist | 0.02 0.016 DBMET01381 0.079 0.006 DBMET01382 0.241 0.004 DBMET01383 | DBMET01383 | |
| 0.017 | 0.028 | 0.031 | Adenosine A1 receptor agonist | 0.031 0.011 DBMET01382 0.027 0.014 DBMET01383 | DBMET01382 | |
| 0.012 | 0.027 | 0.067 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.052 0.004 DBMET01382 0.067 0.003 DBMET01383 | DBMET01383 | |
| 0.006 | 0.028 | 0.072 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.072 0.004 DBMET01381 | DBMET01381 | |
| 0.043 | 0.071 | 0.06 | Angiotensin-converting enzyme inhibitor | 0.06 0.029 DBMET01381 | DBMET01381 | |
| 0.012 | 0.04 | 0.189 | Purinergic P2Y12 antagonist | 0.066 0.005 DBMET01382 0.189 0.004 DBMET01383 | DBMET01383 | |
| 0.026 | 0.057 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET01382 | DBMET01382 | |
| 0.041 | 0.073 | 0.614 | Carbamoyl phosphate synthetase inhibitor | 0.081 0.028 DBMET01381 0.487 0.002 DBMET01382 0.614 0.001 DBMET01383 | DBMET01383 | |
| 0.011 | 0.047 | 0.118 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.032 0.016 DBMET01381 0.112 0.002 DBMET01382 0.118 0.002 DBMET01383 | DBMET01383 | |
| 0.02 | 0.058 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 DBMET01382 0.03 0.011 DBMET01383 | DBMET01382 | |
| 0.009 | 0.058 | 0.06 | Purinergic P2Y1 agonist | 0.055 0.002 DBMET01382 0.06 0.002 DBMET01383 | DBMET01383 | |
| 0.021 | 0.076 | 0.059 | Endothelin-converting enzyme inhibitor | 0.059 0.025 DBMET01381 | DBMET01381 | |
| 0.135 | 0.194 | 0.486 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.131 DBMET01381 0.464 0.005 DBMET01382 0.486 0.004 DBMET01383 | DBMET01383 | |
| 0.049 | 0.11 | 0.681 | Glutamate dehydrogenase inhibitor | 0.076 0.048 DBMET01381 0.415 0.004 DBMET01382 0.681 0.002 DBMET01383 | DBMET01383 | |
| 0.044 | 0.113 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 DBMET01382 | DBMET01382 | |
| 0.06 | 0.139 | 0.517 | NADH dehydrogenase inhibitor | 0.09 0.056 DBMET01381 0.517 0.003 DBMET01382 0.501 0.003 DBMET01383 | DBMET01382 | |
| 0.001 | 0.095 | 0.014 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 DBMET01382 0.008 0.006 DBMET01383 | DBMET01382 | |
| 0.006 | 0.101 | 0.069 | Purinergic P2Y1 antagonist | 0.054 0.004 DBMET01382 0.069 0.003 DBMET01383 | DBMET01383 | |
| 0.063 | 0.167 | 0.268 | Mucolytic | 0.217 0.01 DBMET01382 0.268 0.005 DBMET01383 | DBMET01383 | |
| 0.015 | 0.124 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET01382 | DBMET01382 | |
| 0.049 | 0.169 | 0.31 | Expectorant | 0.235 0.014 DBMET01382 0.31 0.008 DBMET01383 | DBMET01383 | |
| 0.022 | 0.161 | 0.443 | Biliverdin reductase inhibitor | 0.443 0.002 DBMET01382 0.361 0.002 DBMET01383 | DBMET01382 | |
| 0.012 | 0.153 | 0.311 | Purinergic P2Y antagonist | 0.041 0.035 DBMET01381 0.28 0.003 DBMET01382 0.311 0.003 DBMET01383 | DBMET01383 | |
| 0.153 | 0.294 | 0.47 | Antibacterial | 0.248 0.179 DBMET01381 0.47 0.05 DBMET01382 0.303 0.133 DBMET01383 | DBMET01382 | |
| 0.012 | 0.168 | 0.254 | Phosphorylase inhibitor | 0.254 0.004 DBMET01382 0.217 0.005 DBMET01383 | DBMET01382 | |
| 0.128 | 0.289 | 0.445 | Immunosuppressant | 0.445 0.049 DBMET01382 0.338 0.093 DBMET01383 | DBMET01382 | |
| 0.015 | 0.177 | 0.127 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.127 0.002 DBMET01382 0.038 0.005 DBMET01383 | DBMET01382 | |
| 0.011 | 0.183 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | 0.052 0.014 DBMET01382 0.041 0.021 DBMET01383 | DBMET01382 | |
| 0.005 | 0.188 | 0.056 | Sphingosine 1-phosphate receptor 3 agonist | 0.056 0.013 DBMET01382 | DBMET01382 | |
| 0.018 | 0.213 | 0.257 | Purinergic P2X2 antagonist | 0.184 0.006 DBMET01382 0.257 0.003 DBMET01383 | DBMET01383 | |
| 0.014 | 0.217 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET01382 | DBMET01382 | |
| 0.011 | 0.218 | 0.125 | Thymidine phosphorylase inhibitor | 0.125 0.002 DBMET01382 0.049 0.005 DBMET01383 | DBMET01382 | |
| 0.017 | 0.234 | 0.064 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET01382 | DBMET01382 | |
| 0.053 | 0.281 | 0.436 | Adenylate kinase inhibitor | 0.375 0.004 DBMET01382 0.436 0.002 DBMET01383 | DBMET01383 | |
| 0.006 | 0.24 | 0.324 | Phosphoglycerate kinase inhibitor | 0.194 0.004 DBMET01382 0.324 0.002 DBMET01383 | DBMET01383 | |
| 0.012 | 0.288 | 0.028 | DNA polymerase III inhibitor | 0.028 0.02 DBMET01383 | DBMET01383 | |
| 0.039 | 0.319 | 0.14 | Bone formation stimulant | 0.14 0.067 DBMET01382 | DBMET01382 | |
| 0.044 | 0.375 | 0.079 | Hematopoietic | 0.079 0.077 DBMET01382 | DBMET01382 | |
| 0.027 | 0.366 | 0.154 | Anabolic | 0.154 0.016 DBMET01382 0.153 0.016 DBMET01383 | DBMET01382 | |
| 0.007 | 0.356 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET01382 0.025 0.004 DBMET01383 | DBMET01383 | |
| 0.01 | 0.41 | 0.097 | Carbonic anhydrase V inhibitor | 0.097 0.028 DBMET01382 | DBMET01382 | |
| 0.01 | 0.409 | 0.072 | Adenosine deaminase inhibitor | 0.064 0.018 DBMET01382 0.072 0.012 DBMET01383 | DBMET01383 | |
| 0.007 | 0.409 | 0.206 | Acyl-CoA dehydrogenase inhibitor | 0.166 0.008 DBMET01382 0.206 0.005 DBMET01383 | DBMET01383 | |
| 0.042 | 0.466 | 0.153 | Interleukin 6 antagonist | 0.153 0.085 DBMET01382 | DBMET01382 | |
| 0.013 | 0.447 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.073 0.011 DBMET01382 0.053 0.026 DBMET01383 | DBMET01382 | |
| 0.01 | 0.454 | 0.088 | AICAR transformylase inhibitor | 0.088 0.006 DBMET01382 | DBMET01382 | |
| 0.004 | 0.448 | 0.083 | Guanylate cyclase inhibitor | 0.07 0.005 DBMET01382 0.083 0.002 DBMET01383 | DBMET01383 | |
| 0.02 | 0.47 | 0.602 | Cytidine deaminase inhibitor | 0.531 0.005 DBMET01382 0.602 0.004 DBMET01383 | DBMET01383 | |
| 0.008 | 0.461 | 0.265 | Purinergic P2 antagonist | 0.163 0.009 DBMET01382 0.265 0.005 DBMET01383 | DBMET01383 | |
| 0.017 | 0.479 | 0.244 | Purinergic P2X1 antagonist | 0.165 0.005 DBMET01382 0.244 0.002 DBMET01383 | DBMET01383 | |
| 0.001 | 0.513 | 0.014 | Purine nucleoside phosphorylase inhibitor | 0.014 0.005 DBMET01382 0.014 0.005 DBMET01383 | DBMET01383 | |
| 0.04 | 0.552 | 0.241 | DNA repair enzyme inhibitor | 0.241 0.005 DBMET01382 0.125 0.063 DBMET01383 | DBMET01382 | |
| 0.021 | 0.542 | 0.186 | Triose-phosphate isomerase inhibitor | 0.186 0.013 DBMET01382 0.091 0.059 DBMET01383 | DBMET01382 | |
| 0.028 | 0.553 | 0.274 | DNA methylase inhibitor | 0.274 0.037 DBMET01382 0.166 0.104 DBMET01383 | DBMET01382 | |
| 0.005 | 0.533 | 0.032 | Purinergic P2X3 antagonist | 0.032 0.027 DBMET01383 | DBMET01383 | |
| 0.052 | 0.591 | 0.234 | Vasodilator, peripheral | 0.209 0.166 DBMET01382 0.234 0.14 DBMET01383 | DBMET01383 | |
| 0.04 | 0.64 | 0.2 | Vasodilator, coronary | 0.2 0.182 DBMET01383 | DBMET01383 | |
| 0.018 | 0.639 | 0.253 | Aldehyde dehydrogenase inhibitor | 0.253 0.018 DBMET01382 0.227 0.022 DBMET01383 | DBMET01382 | |
| 0.011 | 0.69 | 0.117 | AMP-activated protein kinase stimulant | 0.117 0.052 DBMET01382 | DBMET01382 | |
| 0.007 | 0.691 | 0.103 | Purinergic P2X4 antagonist | 0.069 0.01 DBMET01382 0.103 0.005 DBMET01383 | DBMET01383 | |
| 0.024 | 0.713 | 0.446 | Hexokinase inhibitor | 0.378 0.005 DBMET01382 0.446 0.004 DBMET01383 | DBMET01383 | |
| 0.001 | 0.692 | 0.045 | Adenosine kinase inhibitor | 0.028 0.011 DBMET01382 0.045 0.006 DBMET01383 | DBMET01383 | |
| 0.042 | 0.75 | 0.144 | Sphingosine 1-phosphate receptor 2 agonist | 0.144 0.029 DBMET01382 | DBMET01382 | |
| 0.006 | 0.725 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.031 DBMET01382 | DBMET01382 | |
| 0.009 | 0.761 | 0.051 | Autotaxin inhibitor | 0.051 0.038 DBMET01382 | DBMET01382 | |
| 0.005 | 0.765 | 0.172 | Anesthetic general | 0.172 0.093 DBMET01382 | DBMET01382 | |
| 0.001 | 0.762 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 DBMET01382 0.018 0.015 DBMET01383 | DBMET01383 | |
| 0.043 | 0.82 | 0.216 | Heat shock protein 70 antagonist | 0.161 0.026 DBMET01382 0.216 0.005 DBMET01383 | DBMET01383 | |
| 0.011 | 0.793 | 0.223 | Antithrombotic | 0.223 0.151 DBMET01382 | DBMET01382 | |
| 0.01 | 0.796 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.072 0.025 DBMET01383 | DBMET01383 | |
| 0.004 | 0.816 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.073 DBMET01382 | DBMET01382 | |
| 0.013 | 0.853 | 0.195 | Phospholipase C inhibitor | 0.195 0.047 DBMET01382 | DBMET01382 | |
| 0.005 | 0.848 | 0.149 | Mannose-6-phosphate isomerase inhibitor | 0.149 0.065 DBMET01382 | DBMET01382 | |
| 0.006 | 0.879 | 0.145 | Phosphodiesterase I inhibitor | 0.104 0.039 DBMET01382 0.145 0.018 DBMET01383 | DBMET01383 | |
| 0.003 | 0.888 | 0.34 | Pyruvate kinase inhibitor | 0.141 0.124 DBMET01382 0.34 0.037 DBMET01383 | DBMET01383 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |